Free Trial
NYSE:ELMD

Electromed (ELMD) Stock Price, News & Analysis

Electromed logo
$22.64 -0.58 (-2.50%)
Closing price 05/5/2025 04:00 PM Eastern
Extended Trading
$22.66 +0.02 (+0.08%)
As of 05/5/2025 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Electromed Stock (NYSE:ELMD)

Key Stats

Today's Range
$22.50
$23.22
50-Day Range
$22.11
$27.46
52-Week Range
$13.74
$35.56
Volume
28,159 shs
Average Volume
69,173 shs
Market Capitalization
$193.73 million
P/E Ratio
30.19
Dividend Yield
N/A
Price Target
$38.00
Consensus Rating
Strong Buy

Company Overview

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Electromed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

ELMD MarketRank™: 

Electromed scored higher than 23% of companies evaluated by MarketBeat, and ranked 854th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Electromed is 30.19, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.96.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Electromed is 30.19, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.57.

  • Price to Book Value per Share Ratio

    Electromed has a P/B Ratio of 4.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for ELMD.
  • Dividend Yield

    Electromed does not currently pay a dividend.

  • Dividend Growth

    Electromed does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for ELMD.
  • News Sentiment

    Electromed has a news sentiment score of 1.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Electromed this week, compared to 1 article on an average week.
  • Search Interest

    21 people have searched for ELMD on MarketBeat in the last 30 days. This is an increase of 163% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Electromed to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Electromed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,821,636.00 in company stock.

  • Percentage Held by Insiders

    14.00% of the stock of Electromed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    40.82% of the stock of Electromed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Electromed's insider trading history.
Receive ELMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter.

ELMD Stock News Headlines

Electromed announces $5M share repurchase authorization
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
See More Headlines

ELMD Stock Analysis - Frequently Asked Questions

Electromed's stock was trading at $29.55 on January 1st, 2025. Since then, ELMD shares have decreased by 23.4% and is now trading at $22.64.
View the best growth stocks for 2025 here
.

Electromed, Inc. (NYSE:ELMD) announced its quarterly earnings data on Tuesday, November, 12th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.03 by $0.13. The business earned $14.67 million during the quarter. Electromed had a trailing twelve-month return on equity of 15.71% and a net margin of 11.34%.

Electromed's Board of Directors approved a stock buyback plan on Monday, March 10th 2025, which authorizes the company to repurchase $5,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 2.4% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's board believes its stock is undervalued.

Electromed's top institutional shareholders include Bank of New York Mellon Corp (0.42%), Pekin Hardy Strauss Inc. (0.39%) and Ritholtz Wealth Management (0.16%). Insiders that own company stock include Andrew Summers and Kathleen Skarvan.
View institutional ownership trends
.

Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Electromed investors own include NVIDIA (NVDA), Enterprise Products Partners (EPD), Energy Transfer (ET), Meta Platforms (META), Pfizer (PFE), TransEnterix (TRXDW) and Avino Silver & Gold Mines (ASM).

Company Calendar

Last Earnings
11/12/2024
Today
5/06/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NYSE:ELMD
Employees
160
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$38.00
High Stock Price Target
$38.00
Low Stock Price Target
$38.00
Potential Upside/Downside
+67.8%
Consensus Rating
Strong Buy
Rating Score (0-4)
4.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
30.19
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$5.15 million
Pretax Margin
15.57%

Debt

Sales & Book Value

Annual Sales
$59.63 million
Cash Flow
$0.55 per share
Price / Cash Flow
41.36
Book Value
$5.10 per share
Price / Book
4.44

Miscellaneous

Free Float
7,359,000
Market Cap
$193.73 million
Optionable
Optionable
Beta
0.59
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:ELMD) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners